BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $46,000 | +53.3% | 568 | +42.0% | 0.01% | +125.0% |
| Q1 2019 | $30,000 | -90.7% | 400 | -90.2% | 0.00% | -93.3% |
| Q3 2018 | $321,000 | +3.2% | 4,100 | -19.6% | 0.06% | -15.5% |
| Q2 2018 | $311,000 | +498.1% | 5,100 | +750.0% | 0.07% | +446.2% |
| Q1 2018 | $52,000 | -55.9% | 600 | -64.7% | 0.01% | -50.0% |
| Q3 2017 | $118,000 | -82.2% | 1,700 | -89.8% | 0.03% | -65.8% |
| Q1 2017 | $664,000 | +538.5% | 16,604 | +345.9% | 0.08% | +484.6% |
| Q4 2016 | $104,000 | – | 3,724 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |